Cargando…
Fc multimers effectively treat murine models of multiple sclerosis
Multiple Sclerosis (MS) is a chronic neurodegenerative disease with limited therapeutic options. Recombinant Fc multimers (rFc), designed to mirror many of the anti-inflammatory activities of Intravenous Immunoglobulin (IVIG), have been shown to effectively treat numerous immune-mediated diseases in...
Autores principales: | Wang, Jin, Brown, Kellie, Danehy, Caroline, Mérigeon, Emmanuel, Goralski, Stephen, Rice, Samuel, Torgbe, Kwame, Thomas, Fridtjof, Block, David, Olsen, Henrik, Strome, Scott E., Fitzpatrick, Elizabeth A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10451071/ https://www.ncbi.nlm.nih.gov/pubmed/37638040 http://dx.doi.org/10.3389/fimmu.2023.1199747 |
Ejemplares similares
-
Fully recombinant IgG2a Fc multimers (stradomers) effectively treat collagen-induced arthritis and prevent idiopathic thrombocytopenic purpura in mice
por: Jain, Ajay, et al.
Publicado: (2012) -
Engineering of Fc Multimers as a Protein Therapy for Autoimmune Disease
por: Fitzpatrick, Elizabeth A., et al.
Publicado: (2020) -
An ACE2-IgG4 Fc Fusion Protein Demonstrates Strong Binding to All Tested SARS-CoV-2 Variants and Reduced Lung Inflammation in Animal Models of SARS-CoV-2 and Influenza
por: Merigeon, Emmanuel Y., et al.
Publicado: (2022) -
MHC class I multimers
por: Sun, Mei-Yi, et al.
Publicado: (2001) -
Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis
por: Stockschlaeder, Marcus, et al.
Publicado: (2014)